Export 1816 results:
Autore Titolo Tipo [ Anno(Asc)]
Filtri: First Letter Of Last Name è M  [Clear All Filters]
2011
Marcuzzi A, Zanin V, Crovella S, Pontillo A. Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011). Oral Oncol 2011;47(5):436-7; author reply 438.
Chiaretti A, Ruggiero A, Barbi E, Pierri F, Maurizi P, Fantacci C, Bersani G, Riccardi R. Comparison of propofol versus propofol-ketamine combination in pediatric oncologic procedures performed by non-anesthesiologists. Pediatr Blood Cancer 2011;57(7):1163-7.
Bellini A, Zanchi C, Martelossi S, Di Leo G, Not T, Ventura A. Compliance with the gluten-free diet: the role of locus of control in celiac disease. J Pediatr 2011;158(3):463-466.e5.
Pensiero S, Cecchini P, Michieletto P, Pelizzo G, Madonia M, Parentin F. Congenital aplasia of the optic chiasm and esophageal atresia: a case report. J Med Case Rep 2011;5:335.
Pensiero S, Cecchini P, Michieletto P, Pelizzo G, Madonia M, Parentin F. Congenital aplasia of the optic chiasm and esophageal atresia: a case report. J Med Case Rep 2011;5:335.
De Silva S, Parentin F, Michieletto P, Pensiero S. Corneal curvature and thickness development in premature infants. J Pediatr Ophthalmol Strabismus 2011;48(1):25-9.
Not T, Ziberna F, Vatta S, Quaglia S, Martelossi S, Villanacci V, Marzari R, Florian F, Vecchiet M, Sulic A-M, Ferrara F, Bradbury A, Sblattero D, Ventura A. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut 2011;60(11):1487-93.
Not T, Ziberna F, Vatta S, Quaglia S, Martelossi S, Villanacci V, Marzari R, Florian F, Vecchiet M, Sulic A-M, Ferrara F, Bradbury A, Sblattero D, Ventura A. Cryptic genetic gluten intolerance revealed by intestinal antitransglutaminase antibodies and response to gluten-free diet. Gut 2011;60(11):1487-93.
Zauli G, Voltan R, Bosco R, Melloni E, Marmiroli S, Rigolin GMatteo, Cuneo A, Secchiero P. Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. Clin Cancer Res 2011;17(4):762-70.
Zauli G, Voltan R, Bosco R, Melloni E, Marmiroli S, Rigolin GMatteo, Cuneo A, Secchiero P. Dasatinib plus Nutlin-3 shows synergistic antileukemic activity in both p53 wild-type and p53 mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. Clin Cancer Res 2011;17(4):762-70.
Secchiero P, Perri P, Melloni E, Martini A, Lamberti G, Sebastiani A, Zauli G. Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. Diabet Med 2011;28(10):1277-8.
Secchiero P, Perri P, Melloni E, Martini A, Lamberti G, Sebastiani A, Zauli G. Decreased levels of soluble TNF-related apoptosis-inducing ligand (TRAIL) in the conjunctival sac fluid of patients with diabetes affected by proliferative retinopathy. Diabet Med 2011;28(10):1277-8.

Amministrazione Trasparente